C CELLPOINT
Live / Registered — Registered (as of 10 Sept 2024)
What this means for you
Registered since 10 Sept 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97787004
- Registration number
- 7498517
- Mark type
- Design + words
- Filed
- 08 Feb 2023
- Published for opposition
- 25 Jun 2024
- Registered
- 10 Sept 2024
- Attorney of record
- Alexandra MacKay
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical substances and preparations for human use, namely, pharmaceutical preparations and engineered patient T cells for the treatment of cancer; biopharmaceutical substances and preparations for human use, namely, biopharmaceutical preparations and engineered patient T cells for the treatment of cancer; clinical diagnostic reagents for medical use
- Class 041 — Education and entertainment services: Education services, namely, organizing and conducting conferences, seminars, workshops and classes in the fields of chemistry, medicinal chemistry, biochemistry, biotechnology, drug discovery, drug development and pharmaceuticals; provision of training, namely, provision of training in the fields of chemistry, medicinal chemistry, biochemistry, biotechnology, drug discovery, drug development and pharmaceuticals
- Class 042 — Scientific and technological services: Medical, scientific and industrial research services in the field of pharmaceuticals, engineered patient T-cells, cell therapy, and gene therapy; pharmaceutical and biopharmaceutical research and development services; laboratory analysis and testing services in the field of gene expression, namely, analysis and testing of cells to determine the presence of particular genes; analysis and testing of cells to determine efficacy for treatment of cancer; development, examination, namely, quality control, and testing of pharmaceutical and biopharmaceutical semi-finished products for use in medicaments; development, laboratory analysis and testing of medicaments; development of test systems in the nature of testing procedures and protocols, computer software for testing, reagents and testing kits for testing for pharmaceutical and biopharmaceutical products; development of databases in the medical, pharmaceutical and biopharmaceutical field and development of computer databanks containing information concerning gene expression and gene therapy; pharmaceutical drug development services; scientific research in the nature of conducting clinical trials for others; Providing information about the results of clinical trials for pharmaceutical products; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials
- Class 044 — Medical, beauty and agricultural services: Medical services; medical and pharmaceutical advisory and consultancy services; preparing pharmaceuticals for others being engineered patient T-cells; medical services, namely, Stemcell and celltherapy services; Medical services relating to the removal, treatment and processing of human cells
Owner
- Galapagos NV, Mechelen, BE
- Galapagos NV, Mechelen, BE
- Galapagos NV, Mechelen, BE
Prosecution history
- 10 Sept 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 10 Sept 2024 — REGISTERED-PRINCIPAL REGISTER
- 25 Jun 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 25 Jun 2024 — PUBLISHED FOR OPPOSITION
- 05 Jun 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 16 Feb 2024 — ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
- 09 Feb 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 07 Feb 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 07 Feb 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 07 Feb 2024 — ASSIGNED TO LIE
- 06 Nov 2023 — ASSIGNED TO EXAMINER
- 17 Sept 2023 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 25 Aug 2023 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 25 Aug 2023 — NON-FINAL ACTION E-MAILED
- 25 Aug 2023 — NON-FINAL ACTION WRITTEN